Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

November 15, 2013 (Vol. 33, No. 20)

3D Printing May Revolutionize Drug R&D

Organovo Offers Design Options for Modeling Diverse Tissue Types

  • Differences between animal models and human tissues have contributed to approximately one dozen failures of late-stage drugs in 2012 alone. Organovo is remedying the situation with an innovative tissue development technology that produces fully functional human tissue for research and therapeutic applications. “We can create a number of ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.